SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-762991
Filing Date
2016-11-08
Accepted
2016-11-08 16:17:03
Documents
5
Period of Report
2016-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d194911d8k.htm 8-K 28517
2 EX-2.1 d194911dex21.htm EX-2.1 604535
3 EX-4.1 d194911dex41.htm EX-4.1 108695
4 EX-99.1 d194911dex991.htm EX-99.1 14861
5 GRAPHIC g194911ex991pg1.jpg GRAPHIC 8908
  Complete submission text file 0001193125-16-762991.txt   770463
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 161981483
SIC: 8731 Services-Commercial Physical & Biological Research